Leaflet FLUTICASONE FUROATE GSK 27.5mcg / puf nasal spray, suspension


Indicated for: asthma; chronic obstructive pulmonary disease

Substance: fluticasone furoate (bronchodilator)

ATC: R01AD12 (Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids)

Fluticasone furoate is a corticosteroid mainly used to treat asthma and allergic rhinitis. It reduces inflammation in the airways, helping to relieve symptoms such as coughing, wheezing, and nasal congestion. Regular use helps prevent asthma attacks and keeps allergy symptoms under control.

Fluticasone furoate is usually administered as a nasal spray or inhaler, as directed by your doctor. It is important to use the medication daily, even if you feel well, to achieve the best effect. Do not stop the treatment without your doctor's approval.

Side effects may include irritation of the nose or throat, nosebleeds, hoarseness, or local infections. Rarely, severe allergic reactions or adrenal gland problems may occur. If you experience difficulty breathing or facial swelling, contact your doctor immediately.

Fluticasone furoate is effective in controlling asthma and allergy symptoms, but correct use and medical monitoring are necessary to prevent complications and ensure treatment effectiveness.

General data about FLUTICASONE FUROATE GSK 27.5mcg / puf

  • Substance: fluticasone furoate
  • Date of last drug list: 01-07-2013
  • Commercial code: W53540001
  • Concentration: 27.5mcg / puf
  • Pharmaceutical form: nasal spray, suspension
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for fluticasone furoate

  • 27.5mcg
  • 27.5mcg/puf

Combinations with other substances